Mission
Technology for Health
Vision
To Be a Global Leading Technology-Driven Pharmaceutical Manufacturer
Apeloa, founded in 1989, is a publicly traded company as part of the Hengdian Group. Headquartered in Hengdian, Zhejiang, Apeloa has over 7,000 employees worldwide. Apeloa is China's top 2 exporter of APIs and the top 5 CDMO companies. It also ranks 36th among China’s pharmaceutical companies.
Apeloa’s core businesses include API, CDMO, FDF, and ACI, with seven API manufacturing sites (five chemical synthesis and two fermentation) and two drug product sites. Our products cover cardiovascular, anti-infection, psychotropic, and anti-cancer treatments, with production bases in Zhejiang, Shandong, and Anhui. Since 2007, our main API manufacturing sites have passed audits by NMPA, US FDA, EMEA, and PMDA, establishing us as a leading API enterprise. Our CDMO business maintains strategic partnerships with top pharmaceutical companies globally, offering comprehensive services and sustaining high growth. Apeloa’s brands, "Baishixin" and "Tianliwei," have been widely recognized, and our first extended-release product has successfully entered the U.S. market.
Apleoa implements the development strategy of "Global API Leader, CDMO Excellence, High-quality & Affordable Medicine, Expanding Aesthetic & Care Ingredients", with annual R&D expenses exceeding 5% of revenue. We support leading technology platforms with over 1,300 scientists and collaborations with top universities. Our philosophy emphasizes technology driven, high-standard compliance, and cost efficiency, aiming to be a global leading technology-driven pharmaceutical manufacturer.
Top 36 Chinese pharmaceutical industry enterprises
Ranked 2nd in the Country for the Export of Chemical API
Top 5 Small Molecule CDMO Companies in China
R&D Team of More Than 1,200 People
Technology for Health
To Be a Global Leading Technology-Driven Pharmaceutical Manufacturer
Mr. Fangmeng Zhu (Brian Zhu), Holds a master degree, a CEIBS EMBA, a senior engineer and economist, joined Apeloa in 1997 and has more than 20 years of experience in the pharmaceutical industry, who is the current chairman and CEO of Apeloa.
Chairman & CEO
Mr. Xinliang Xu, holds a CEIBS EMBA, is a senior engineer, joined Apeloa in 1992 and has more than 30 years working experience in the pharmaceutical and chemical industry, and he is the vice chairman of Apeloa.
Vice Chairman
Mr. Chun He, holds a CEIBS EMBA, is a senior engineer, joined Apeloa in 1998 and he is the president of Apeloa.
President & Head of ACI BU
Mr. Min Jin, holds a CEIBS EMBA, is a senior economist, has more than 20 years experience in pharmaceutical and chemical industry. He is the SVP.
Senior Vice President
Mr. Lei Cai (George Cai), holds a master degree, a CEIBS EMBA. He is the Corporate VP, head of CDMO BU of Apeloa.
Corporate Vice President & Head of CDMO BU
Mr. Yuwang Zhou, Economist. In August 2003, he obtained the certificate of Secretary of the Board of Directors of listed companies issued by the Shenzhen Stock Exchange.
Vice President & Secretary of the Board
Mr. Jinhui Zhang, has a master degree and is a senior accountant.
CFO
Mr. Qing Chen, is a senior engineer.
Assistant President
Mr. Yonglong Li (Ray Li) , holds a master degree, a CEIBS EMBA in progress. He is head of API BU of Apeloa.
Head of API BU
Mr. Liang Yu, is head of FDF BU of Apeloa and has rich experience in R&D and sales.a CEIBS EMBA in progress.
Head of FDF BU
Apeloa Scientific Advisory Board established in December 2022, abbreviated as "ASAB". The ASAB is dedicated to providing strategic direction and planning advice for the company, participating in the initiation and evalsuation of major projects, and the recruitment and development of key talents. It offers recommendations on the adoption and application of advanced technologies, enhancing the professionalism and scientific rigor of Apeloa's strategic decision-making. This will propel Apeloa to the forefront of biomedical manufacturing technology both domestically and internationally, helping it to become a leading technology-driven pharmaceutical manufacturing company in China.
The inaugural ASAB is composed of five renowned experts in the field of biomedicine, specializing in areas such as organic chemical synthesis, synthetic biology, biomanufacturing engineering technology, chemical engineering and microfluidic technology, pharmaceutical engineering and processes, and drug molecular design and process development.
Apeloa Pharmaceutical Co., Ltd.
Add：399 Jiangnan Road, Hengdian, Dongyang, Zhejiang 322118, China
Apeloa Headquarter
Functional Management Service Centre
Apeloa API R&D Center
Add：368 Jiangnan Second Road, Hengdian, Dongyang, Zhejiang 322118, China
5,400 square meters
Research and technical improvement for APIs and Intermediates
Crystallization & Particle Engineering and Synthetic Biology & Biocatalysis technology platform
Apeloa CDMO (Hengdian) R & D Center
Add：368 Jiangnan Second Road, Hengdian, Dongyang, Zhejiang 322118, China
8,200 square meters
Capacity for 500+ R&D personnel
Process development/optimization/CMC
Technology platform (Peptide, high potency and flow chemistry)
Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd.
Add：519 Jiangnan Road, Hengdian, Dongyang, Zhejiang 322118, China
140,000 square meters
Clinical/commercial API manufacturing services
Passed USFDA and PMDA inspection
Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
Add：368 Jiangnan Second Road, Hengdian, Dongyang, Zhejiang 322118, China
250,533 square meters
Pre-clinical, clinical/commercial API manufacturing services
Passed USFDA and PMDA inspection
Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
Add：333 Jiangnan Road, Hengdian, Dongyang, Zhejiang 322118, China
460,000 square meters
Pre-clinical, Clinical/commercial API and drug product manufacturing services
Passed USFDA and PMDA inspection
Zhejiang Apeloa Biotechnology Co., Ltd.
Add：Geshan Industrial Zone, Dongyang, Zhejiang 322109, China
141,000 square meters
Microbial fermentation manufacturing service for API
Passed USFDA, EDQM and PMDA inspection
Hangzhou Apeloa Medicine Research Institute Co., Ltd.
Add：4-202, No. 291 Fucheng Rd. Xiasha, Jianggan, Hangzhou Zhejiang 310016, China
2,700 square meters
Research and CMC service for drug product
Innovative formulation technology platform
Zhejiang Hengdian Apeloa Imp. & Exp.Co., Ltd.
Add：13/F, T1, Hengdian Center, No. 136 Fuchun Road, Shangcheng District, Hangzhou, Zhejiang 310016, China
Top3 exporter in China (API & Intermediate)
Global business development headquarter
Apeloa (Shanghai) Pharma Solutions Co., Ltd.
Add：No.8666, Shanghai Zhicheng Building 8, Xuanqiaozhen Hunan Highway, Pudong, Shanghai 201314, China
6,400 square meters
300+chemists
Process development/optimization/CMC
Zhejiang Jutai Pharmaceutical Co., Ltd.
Add：51 Donggang Road 1st, Kecheng District,Quzhou ,Zhejiang 322118，China
Cephalosporins and penicillins production base
Covering an area of 70,000 square metres
Formulation CMO Custom Services
Anhui Apeloa Biotechnology Co., Ltd.
Add：Dongzhi Economic Developing Area, Anhui 247260, China
360,000 square meters
Microbial fermentation/chemical synthesis manufacturing service for API and intermediate
Passed NMPA and EDQM inspection
Shandong Apeloa Tospo Pharmaceutical Co., Ltd.
Add：Lingang Indutrial Park, Binhai Economic and Technological Development Zone, Weifang, Shandong 261000, China
293,000 square meters
Chemical synthesis manufacturing service
Manufacturing capability for challenging chemistry (Fluorination)
Shandong Apeloa Hanxing Medical Co., Ltd.
Add：Binhai (Xiaying) Economic Development Zone, Changyi, Weifang, Shandong 261000, China
350,000 square meters
Chemical synthesis manufacturing service
APELOA PHARMA SOLUTIONS
Add：35 Dunham Road, Billerica, MA 01821
Operational as of May 2024
1,500 square meters
Tech Development Platform
Early stage discovery/lead optimization/process development and scale-up service (GLP batch)
APELOA Europe GmbH
Add：Friedrich-Ebert-Anlage49th/23rdfloor Frankfurt am Main, Germany 60308
Founded in Nov 2022
Business development office
A bridge between China and Europe
APELOA Japan Office
Add：7F, 6-20-2, Shinbashi, Minato-ku, Tokyo
Founded in Jan 2024
Business development office
A bridge between China and Japan
